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Abstract
The broad use of transgenic and gene-targeted mice has established bone marrow-derived macrophages (BMDM) as
important mammalian host cells for investigation of the macrophages biology. Over the last decade, extensive research has
been done to determine how to freeze and store viable hematopoietic human cells; however, there is no information
regarding generation of BMDM from frozen murine bone marrow (BM) cells. Here, we establish a highly efficient protocol to
freeze murine BM cells and further generate BMDM. Cryopreserved murine BM cells maintain their potential for BMDM
differentiation for more than 6 years. We compared BMDM obtained from fresh and frozen BM cells and found that both are
similarly able to trigger the expression of CD80 and CD86 in response to LPS or infection with the intracellular bacteria
Legionella pneumophila. Additionally, BMDM obtained from fresh or frozen BM cells equally restrict or support the
intracellular multiplication of pathogens such as L. pneumophila and the protozoan parasite Leishmania (L.) amazonensis.
Although further investigation are required to support the use of the method for generation of dendritic cells, preliminary
experiments indicate that bone marrow-derived dendritic cells can also be generated from cryopreserved BM cells. Overall,
the method described and validated herein represents a technical advance as it allows ready and easy generation of BMDM
from a stock of frozen BM cells.
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Introduction
Macrophages are essential for both the innate and adaptive
immune system, as they play key roles in different biological
processes, such as antigen presentation and processing, microbial
killing, cytokine production, and clearance of apoptotic cells,
among others [1,2,3]. Consequently, murine macrophages have
become an important host cell model for investigation of
mammalian macrophage functions. Therefore, there is great
demand for a homogeneous macrophage population on which to
conduct such immunological investigations. Because differentiated
primary macrophages display limited multiplication, several
investigators have used immortalized macrophage-like myeloid
cell lines, such as J774A.1, RAW264.7 and P388D1. However,
these cells usually differ from primary macrophages, as the
selective pressure imposed by continual subculture usually results
in the loss of genes that are not important for multiplication yet are
key for macrophage immune functions.
Regardless of the deficiencies of macrophage-like cells, the
broad use of transgenic and gene-disrupted mice has emphasized
the need for cultures of primary cells explanted from these
animals. Currently, the three major choices for primary mouse
macrophages are peritoneal macrophages (PM), alveolar macro-
phages (AM) and bone marrow-derived macrophages (BMDM).
Although resident PM and AM can be readily harvested from the
mouse, the yield is low and the macrophages’ biology is severely
affected by the sanitary conditions of the animal facility. In
contrast, BMDM are fully differentiated in vitro from bone marrow
(BM) stem cells and therefore are naı ¨ve regardless of the health
conditions of the donor mice. In addition, high numbers of
BMDM can be obtained from a single mouse. These features have
favored the choice of BMDM as a macrophage model in most
immunological studies.
Over the last decade, methods to freeze and store viable
hematopoietic human cells have been extensively investigated
[4,5,6,7]. However, to the best of our knowledge, there is no
information related to how to prepare murine BMDM from frozen
BM cells. Here, we establish a highly efficient protocol for freezing
murine BM cells and further generating BMDM. We further
compared BMDM obtained from fresh or previously frozen BM
cells and found that both BMDM are similarly able to express
stimulatory and co-stimulatory molecules in response to inflam-
matory stimuli and to respond to infection by the intracellular
bacterial pathogen Legionella pneumophila.
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Preparation of murine bone marrow cells
The protocols for animal handling were previously approved by
our institutional Animal Ethics Committee (CETEA/FMRP,
protocol number 006/2008). Femurs were obtained from 6–12
week old C57BL/6 mice. After euthanasia, the mice were sprayed
with 70% ethanol and the femurs were dissected using scissors,
cutting through the tibia below the knee joints as well as through
the pelvic bone close to the hip joint. Muscles connected to the
bone were removed using clean gauze, and the femurs were placed
into a polypropylene tube containing sterile PBS on ice. In a tissue
culture hood, the bones were placed in 70% ethanol for 1 minute,
washed in sterile RPMI 1640 and then both epiphyses were
removed using sterile scissors and forceps. The bones were flushed
with a syringe filled with RPMI 1640 to extrude bone marrow into
a 15 mL sterile polypropylene tube. A 5 ml plastic pipette was
used to gently homogenize the bone marrow. The cell suspension
generated thereafter is called fresh bone marrow cells.
Freezing and thawing bone marrow cells
Fresh bone marrow cells were counted using a hemocytometer,
centrifuged for 5 minutes at 2006g at 4uC and gently resuspended
to obtain a solution containing from 4 to 6610
6 cells/ml (unless
otherwise mentioned) in freezing media containing 90% fetal
bovine serum and 10% DMSO (unless otherwise mentioned).
Each milliliter of the solution was added to an individual cryovial,
maintained in a 280uC freezer for 24 hours and then transferred
to a liquid nitrogen tank. To thaw the cells, a cryovial was quickly
transferred to a 37uC water bath until the suspension was
completely thawed. The contents were then transferred to plastic
tubes containing 10 ml of 37uC PBS. The cells were centrifuged at
2006 g for 5 minutes and resuspended in bone marrow dif-
ferentiation media as described below.
Differentiation of bone marrow-derived macrophages
Fresh or frozen bone marrow cells were used to generate BMDM
as previously described [8], using L929-cell conditioned medium
(LCCM) as a source of granulocyte/macrophage colony stimulating
factor [9]. The cells were resuspended in 10 ml bone marrow
differentiation media (R20/30), which is RPMI1640 supplemented
with 20% fetal bovine serum (Gibco, cat. 12657-029), 30% LCCM,
100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-
glutamine. Cells were seeded in non-tissue culture treated Optilux
Petri dishes (BD Biosciences) and incubated at 37uC in a 5% CO2
atmosphere. Four days after seeding the cells, an extra 10 ml of
fresh R20/30 were added per plate and incubated for an additional
3 days. To obtain the BMDM, the supernatants were discarded and
the attached cells were washed with 10 ml of sterile PBS. Ten ml of
ice-cold PBS were added to each plate and incubated at 4uC for 10
minutes. The macrophages were detached by gently pipetting the
PBS across the dish. The cells were centrifuged at 2006 g for 5
minutes and resuspended in 10 ml of BMDM cultivation media
(R10/5), which is composed of RPMI 1640, 10% fetal bovine
serum,5%LCCMand2 mML-glutamine.Thecellswerecounted,
seeded and cultivated in tissue culture plates 12 hours before any
further experimental procedure.
Bacterial infection
Legionella pneumophila Lp01 [10] and isogenic mutants deficient
for flagellin (flaA) [11] were used in this study. Bacteria were grown
on charcoal yeast extract agar (BCYET: 1% yeast extract, 1% N-
(2 acetoamido)-2-aminoethaneosulfonic (ACES) pH 6.9, 3.3 mM
L-cysteine, 0.33 mM Fe(NO)3, 1.5% bacto agar and 0.2%
activated charcoal, supplemented with 100 mg/ml thymidine) at
37uC for 48 hours as previously described [12]. For infections,
bacteria were resuspended in sterile water and diluted to an
appropriate multiplicity of infection (MOI) based on optical
density (OD) at 600 nm. L. pneumophila growth curves in BMDM
was assessed as previously described [13]. Briefly, BMDM were
added to 24-well plates at a density of 2610
5 cells per well and
wild type L. pneumophila or flaA were added to each well at an MOI
of 0.015. Macrophages were lysed in sterile water after 48 hours of
infection and the cell lysates were combined with the tissue culture
supernatant for each respective well, ensuring that all bacteria in
the well would be counted. Serial dilutions from each well were
plated on BCYET plates. Colony forming units were assessed by
counting the bacterial colonies present after 96 hours of incu-
bation at 37uC. For determination of the frequency of bacteria per
LCV, BMDMs were seeded at 2610
5 cells/well on 13-mm glass
Figure 1. Determination of the optimal DMSO concentration for cryopreservation of bone marrow cells. Bone marrow (BM) cells were
resuspended in heat-inactivated fetal bovine serum containing 0, 5, 10, 15 or 20% DMSO and then stored in liquid nitrogen for one week. Cells were
thawed and counted to estimate the number of BM cells after thawing (white bars) and were then cultivated in bone marrow differentiation media.
After 7 days of differentiation, the cultures were washed with ice cold PBS to remove undifferentiated cells and the bone marrow derived
macrophages (BMDM) were detached from the plates and counted (black bars). The dotted line represents the initial number of frozen BM cells per
aliquot.
doi:10.1371/journal.pone.0015263.g001
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were infected with L. pneumophila with an MOI of 10 followed by
centrifugation at 2006g for 5 minutes and incubation for 1 hour
to allow phagocytosis. The cells were further washed 3 times with
PBS and incubated for an additional of 4 or 6 hours. The cultures
were fixed and permeabilized for 10 minutes in ice-cold methanol.
Coverslips were washed with PBS and blocked in PBS containing
5% BSA and 2% goat serum for 1 hour. Bacteria were stained
with a rabbit anti-L. pneumophila polyclonal antibody (1:2000),
followed by Alexa-488-conjugated goat anti-rabbit secondary
antibody (1:300 dilution, Invitrogen) and analyzed in a Leica
TCS SP2 SE inverted microscope using a 40x/1.25 oil objective
(Leica HCX PL APO).
Flow cytometry
For flow cytometry experiments, BMDM and BMDCs were
seeded and cultivated in non-tissue culture-treated 6-well plates at
a density of 1610
6 cells per well. Cultures were treated with 1 mg/
Figure 2. Fresh or cryopreserved bone marrow cells show similar expression of cell markers. Cells from fresh or cryopreserved (frozen)
bone marrow were harvested and labeled with phycoerythrin (PE)-conjugated Abs against CD29, CD31, CD34, CD44, CD45, CD73, CD90, CD105, Sca-1
and PDGF or control IgGs and analyzed by FACS. (A) Dot plot showing the two gates analyzed (G1 and G2). (B and C) Averages and standard deviation
of the triplicates show the percentages of the cells positive for each marker within the gated population: G1 (B) or G2 (C). Data are one representative
experiment out of two independent experiments performed. No statistically significant differences were detected between fresh or frozen BM cells
(P.0.05).
doi:10.1371/journal.pone.0015263.g002
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type L. pneumophila at an indicated MOI. After 18 hours incu-
bation, macrophages and dendritic cells were removed from the
plates with ice-cold PBS and stained with the following antibodies:
PE-Cy7 anti-mouse CD11c (BD Pharmingen, clone HL3), APC
anti-mouse MHC-II (eBioscience, clone M5/114.15.2), FITC
anti-mouse CD86 (BD Pharmingen, clone GL-1), PE anti-mouse
CD40 (eBioscience, clone 1C10), APC-Cy7 anti-mouse CD11b
(BD Pharmingen, clone M1/70) and PercP anti-mouse F4/80
(eBioscience, clone BM8). The isotype controls were rat IgG2a
(R35-95), rat IgG2b (A95-1), and hamster IgG2 (Ha4/8), all from
BD Pharmingen. For stem cells staining, fresh and cryopreserved
bone marrow cells were added to FASC tube at a density of 1610
6
cells per tube. Cells were staining with phycoerythrin (PE)-
conjugated antibodies against: CD29 (eBioHMb1.1); CD34
(RAM34); CD44 (IM7); CD45 (30-F11); CD90 (53-2.1); CD105
(MJ7/18); Sca-1 (D7); PDGF (APB5); CD31 (BD cat. 553373);
CD73 (BD cat. 550741) and isotype control (eB149/10H5) from
BD Pharmingen. Briefly, cells were washed, incubated with an
anti-FcRIII/II mAb (2-4G.1) in PBS containing 0,1% BSA and
0,01% NaN3 and stained for 30 minutes at 4uC. Data were
acquired with a FACSCantoII (Benton Dickinson) and analyzed
with FlowJo Software (Tree Star).
Leishmania amazonensis infection
Promastigotes of the L. amazonensis constitutively expressing GFP
(La-GFP; MHOM/BR/73M2269) were kindly provided by Dr.
Silvia R. Uliana (ICB/USP). Parasites were cultured in Schneider’s
Drosophila medium (Invitrogen, Carlsbad, CA), pH 7.0, supple-
mented with 20% heat-inactivated fetal calf serum (GIBCO BRL),
100 U/ml penicillin G potassium (USB Corporation, Cleveland,
OH, USA), 2 mM L-glutamine and 2% human urine, pH 6.5, at
26uC. BMDM were harvested and infected with La-GFP at 10:1
parasite-to-cell ratio. After 6 h of infection, extracellular parasites
were washed and fresh media were added. The percentage of GFP
+
BMDM and the GFP MIF was determined after 48 h of infection
by flow cytometry [14]. Damaged cells were revealed by staining
cells with 10 mg/ml solution of propidium iodide (PI; Sigma) added
5 minutes before the FACS measurements.
Generation of Dendritic cells
Dendritic cells (DC) were generated in vitro from bone marrow
cells from 6- to 8-wk-old wild type C57BL/6 as previously
described [15]. Briefly, femurs and tibias were flushed with RPMI-
1640 (Gibco-BRL Life Technologies, Grand Island, NY) to release
the BM cells that were cultured in 24-well-culture plates in RPMI-
1640 (Gibco) supplemented with 10% heat-inactivated FCS,
100 mg/ml of penicillin, 100 mg/ml of streptomycin, 5610
25 M
2-mercaptoethanol (all from Sigma), 20 ng/ml murine granulo-
cyte-macrophage colony-stimulating factor (GM-CSF, Invitrogen).
On day 3, the supernatants were gently removed and replaced
with the same volume of media. On day 6, the non-adherent cells
were collected and submitted to a positive selection using anti-
CD11c magnetic beads, according to the manufacturer’s instruc-
tions (Miltenyi Biotec). Flow cytometry evaluation of purified DC
shows that more than 91% of cells were CD11c positive.
Results
Determination of the optimal DMSO concentration and
numbers of BM cells
Cryopreservation methods usually use dimethyl sulfoxide (DMSO)
to prevent the formation of ice crystals that damage membranes
[16]. Because the DMSO concentrations vary among the protocols
for freezing immortalized cell lines, we first investigated the optimal
DMSO concentration to be used in a protocol to freeze bone
marrow cells, which should remain viable to allow further gene-
ration of BMDM. We initially used 3610
7 cells from a single mouse
and divided them into 5 identical aliquots containing 6610
6 cells
each. These aliquots were then resuspended in fetal bovine serum
containing 0, 5, 10, 15 and 20% DMSO and were stored in liquid
nitrogen for one week. After thawing, we estimated the numbers of
viable bone marrow cells per frozen vial and found that cells that
were frozen in 90% FBS +10% DMSO yielded the highest recovery
of intact cells (Fig. 1, white bars). We further used these thawed cells
to generate bone marrow derived macrophages and found that the
highest recovery of differentiated BMDM was obtained when 10%
DMSO was used to freezethe bone marrow cells (Fig.1, blackbars).
Collectively, these data indicate that viable BM cells can be
maintained frozen, and once thawed, they can readily be used to
generate BMDM. The solution containing 10% DMSO in 90%
fetal bovine serum seems most appropriate for the cryopreservation
Figure 3. Numbers of frozen bone marrow cells per differen-
tiated bone marrow-derived macrophages. Bone marrow cells






7 cells/vial. The cells
were thawed and cultivated in bone marrow differentiation media for 7
days. The cultures were washed with ice cold PBS to remove
undifferentiated cells and the bone marrow derived macrophages
(BMDM) were detached from the plates and counted. The figure shows
the non-linear correlation between the number of frozen BM cells (x-
axis) and the number of differentiated BMDM (y-axis).
doi:10.1371/journal.pone.0015263.g003
Figure 4. Frozen bone marrow cells maintain differentiation
competence over time. Bone marrow cells were frozen at a
concentration of 4610
6 cells per vial at different times and maintained
in liquid nitrogen. Eight aliquots were simultaneously thawed and the
cells were cultivated in bone marrow differentiation media. After 7 days
of differentiation, the cultures were washed with ice cold PBS to remove
undifferentiated cells and the bone marrow derived macrophages
(BMDM) were detached from the plates and counted.
doi:10.1371/journal.pone.0015263.g004
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affects the viability of BM cell populations, we used a several surface
markers of BM cells to evaluate the percentages of specific cell
populations before and after the freezing process. As shown in
figure2,thepercentagesofBMcellsexpressingCD29,CD31,CD34,
CD44, CD45, CD73, CD90, CD105 and Sca-1 was not altered in
fresh of cryopreserved BM cells,thus indicating that freezing protocol
may not differentially affect specific BM populations.
Next, we investigated the optimal number of bone marrow cells to
be added to each cryovial in order to recover the maximum number
of BMDM. Thus, we obtained cells from a single mouse and froze
1.4610
6,2 . 7 610
6,4 . 2 610
6,6 . 4 610
6 or 1.4610
7 BM cells per
cryovial. The vials were further thawed and the cells were
differentiated into BMDM. When we used low numbers of frozen
BM cells per cryovial, we found a direct correlation between the
number of frozen BM cells and the number ofdifferentiated BMDM
recovered(Fig.3).However,whenweaddedhighernumbersofcells,
i.e., 5610
6 BM cells, we obtained less BMDM than expected in a
linear regression. It is possible that differentiation efficiency was
decreased due to saturation of the nutrients in the media. Based on
the data shown in Figure 3, we estimate that addition of 4 to 6610
6
BM cells/vial is appropriate for BMDM generation.
Frozen BM cells maintain differentiation capacity for at
least 6 years
The freezing method described herein is very useful as it allows
for the storage of viable BM cells that can be used for further
generation of BMDM. Therefore, it is important to know how
long the frozen BM cells can retain differentiation competence.
Thus, over the past 6 years, we have frozen BM cells at a
concentration of 4610
6 cells/vial in a 10% DMSO, 90% FBS
solution and maintained them in liquid nitrogen. In a single
experiment, we thawed 8 of these vials and evaluated competence
for BMDM differentiation. Over 6 years of storage, we did not
detect any loss in differentiation capacity (Fig. 4). Although we did
not calculate the differentiation ability for BM cells frozen for over
6 years, we believe that these cells can remain competent for
differentiation for even longer periods, as previously reported for
cryopreserved human stem cells [17].
BMDM obtained from fresh or frozen BM cells trigger
equal expression of CD80 and CD86 in response to
inflammatory stimulus
Further investigation of the biological functions of BMDM
obtained from frozen BM cells is required for routine use of
this protocol. Therefore, we investigated important macrophage
functions, such as expression of stimulatory molecules and the
ability to restrict or support the multiplication of pathogenic
microbes [3]. Thus, we aimed to compare the BMDM obtained
from fresh or frozen BM cells with respect to expression of surface
molecules, such as CD80 and CD86. For this comparison, BMDM
were either stimulated with E. coli LPS or with the intracellular
bacteria Legionella pneumophila and expression of CD80 and CD86
was assessed by FACS. As shown in Figure 5, BMDM readily
Figure 5. Bone marrow-derived macrophage obtained from fresh or cryopreserved bone marrow cells similarly express CD80 and
CD86 in response to LPS and Legionella pneumophila. BMDMs obtained from fresh or cryopreserved (frozen) bone marrow cells were left
untreated (NS), stimulated with 1 mg/ml LPS or infected with L. pneumophila at an MOI of 0.5, 1 and 2. Cultures were cultivated in non-tissue culture-
treated 6 well-plates at a density of 1610
6 BMDM per well and stimulated/infected for 18 hours. Cells were stained for CD11b, F4/80, CD80 and CD86
and evaluated by flow cytometry. Plots were gated on CD11b
+ cells. Shown are the percentage of cells F4/80
+CD80
+ (A) and F4/80
+CD86
+ (C). The
mean fluorescence intensities are shown for CD80 (B) and CD86 (D). Data are representative of those found in three independent experiments.
Asterisks indicate statistically significant differences in relation to NS (P,0.05). No statistically significant differences were detected between BMDM
obtained from fresh or frozen BM cells (P.0.05).
doi:10.1371/journal.pone.0015263.g005
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pneumophila infection. Importantly, BMDM obtained from fresh or
frozen BM cells did not differ in expression of these molecules
either in response to LPS or live L. pneumophila (Fig. 5).
Dendritic cells can be generated from cryopreserved BM
cells and equally trigger expression of CD40, CD86 and
MHC-II in response to LPS
Although the aim of our study was to evaluate generation and
functions of BMDMs from cryopreserved BM cells, we also
preformed preliminary studies to assess the application of the
method for generation of bone marrow-derived dendritic cells
(BMDCs). We found that cryopreserved BM can effectively be
differentiated to DCs in presence of GM-CSF. Furthermore, we
found that BMDCs obtained from fresh or frozen BM cells equally
trigger the expression of molecules such as CD40, CD86 and
MHC-II in response to LPS stimulation (Fig. 6).
BMDM obtained from fresh or frozen BM cells equally
restrict and support the multiplication bacterial
pathogen L. pneumophila and the protozoan
parasite L. amazonensis
Next, we investigated if BMDM obtained from fresh or frozen
BM cells differ in their ability to support the intracellular repli-
Figure 7. Bone marrow-derived macrophages obtained from fresh or frozen bone marrow cells respond similarly to infection with
Legionella pneumophila. (A) Bone marrow-derived macrophages (BMDM) obtained from fresh (open squares) or cryopreserved (frozen; closed
circles) bone marrow (BM) cells were infected with wild type L. pneumophila (Lp01, continuous lines) or with flagellin-deficient L. pneumophila (flaA
-,
dashed lines). BMDM were cultivated and infected in 24-well plates with the indicated Legionella strain at an MOI of 0.015. After 48 hours post-
infection, cells were lysed and the colony-forming units (CFU) were estimated for each of the triplicate wells. (B) Fresh (white bars) or frozen (black
bars) BMDMs were infected with Lp01 at an MOI of 10 for 1 hour. Cultures were vigorously washed with PBS and further incubated for a total of
9 hours of infection. Bacteria were stained with a rabbit anti-L. pneumophila polyclonal antibody and the number of bacteria per individual LCV were
enumerated using an epifluorescence microscope. Shown are the frequencies of LCV containing: 1; 2–3; 4–10; and more than 10 bacteria (.10). At
least 100 LCV in independent cells were scored per each of the triplicate coverslips. Data are representative of those found in three (A) or two (B)
independent experiments. No statistically significant differences were detected between BMDM obtained from fresh or frozen BM cells (P.0.05).
doi:10.1371/journal.pone.0015263.g007
Figure 6. Bone marrow-derived dendritic cells obtained from fresh or cryopreserved bone marrow cells showed similar expression
of CD40, CD86 and MHC-II in response to LPS. Bone marrow-derived dendritic cells (BMDCs) obtained from fresh or cryopreserved (frozen)
bone marrow cells were either left untreated or stimulated with 1 mg/ml LPS for 24 h. BMDCs were stained for CD11b, CD11c, CD40, CD86 and MHC-II
and analyzed by flow cytometry. Plots were gated on CD11b
+ cells. Shown are the percentages (A) and mean fluorescence intensities (B) of CD11c
+
cells expressing CD40, CD86 or MHC-II in response to LPS treatment. Data are representative of those found in two independent experiments. No
statistically significant differences were detected between BMDCs obtained from fresh or frozen BM cells (P.0.05).
doi:10.1371/journal.pone.0015263.g006
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used L. pneumophila, which is a gram-negative, facultative intra-
cellular bacterium that possesses the ability to replicate within
macrophages [18]. Importantly, while wild type L. pneumophila is
eliminated by C57BL/6 macrophages, mutants deficient for
flagellin were shown to bypass macrophage innate immunity and
to multiply in macrophages [11,19,20]. Thus, we used wild type
and flaA mutants of L. pneumophila to assess the ability of BMDM to
restrict or support intracellular microbial replication. We found
that BMDM obtained from fresh or frozen BM cells differ neither
in their ability to restrict intracellular multiplication of wild type
bacteria nor in their ability to support intracellular replication of
flaA mutant bacteria (Fig. 7A). To further evaluate the intracellular
replication of wild type bacteria in macrophages we employed a
highly sensitive single cell analysis to evaluate the number bacteria
per LCV formed after 9 hours infection in BMDM obtained from
fresh or cryopreserved BM cells. We found that the frequency of
the number of bacteria per LCV was not altered in BMDM
obtained from fresh or frozen BM cells (Fig. 7B). Therefore, these
cells did not differ for early restriction of L. pneumophila replication
in BMDMs. Next, we compared the replication of the pathogenic
protozoan parasite Leishmania (L.) amazonensis in BMDM obtained
from fresh or cryopreserved BM cells. We used a L. amazonensis
expressing GFP to quantify the parasite replication by FACS. We
found that BMDM obtained from fresh and frozen BM cells are
equally able to support the intracellular replication of L.
amazonensis (Fig. 8). To further evaluate cell death induced in
response to infection we stained the infected BMDM with
propidium iodide and found that infection did not trigger cell
permeabilization regardless to the BMDM used (Fig. 8D, E).
Collectively, these data indicate that freezing BM cells did not
interfere with BMDM functions, such as their ability to eliminate
Figure 8. Bone marrow-derived macrophage obtained from fresh or cryopreserved bone marrow cells respond similarly to the
infection with Leishmania amazonensis. Bone marrow-derived macrophages (BMDM) obtained from fresh or cryopreserved (frozen) bone marrow
cells were infected with L. amazonensis promastigotes constitutively expressing the GFP at an MOI of 10 parasites per cell. After 48 h and 96 h of
infection, the percentages of L. amazonensis-GFP
+ and propidium iodide-positive cells were estimated by flow cytometry. (A) Percentage of GFP
+
BMDM obtained from fresh (white bars) and frozen (black bars) BM cells. (B) Mean fluorescence intensities (MIF) for GFP signal. (C) Representative
images of cultures infected for 48 h e 96 h with L. amazonensis GFP. (D) FACS profiles of BMDM obtained from fresh and frozen BM cells infected with
L. amazonensis GFP. Shown are the percentages of cells with signal for GFP and PI. (E) Bar graphics indicating the percentage of propidium iodide-
positive cells in uninfected cultures (control), cells treated with 0.05% Tween 20 (Tween) or after infection with L. amazonensis for 48 and 96 hs. Data
are representative of those found in three independent experiments. No statistically significant differences were detected between BMDM obtained
from fresh or frozen BM cells (P.0.05).
doi:10.1371/journal.pone.0015263.g008
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bacterial pathogens.
Discussion
Over the last two decades, the wide use of transgenic and gene-
disrupted mice has had a striking impact on cell biology, microbial
pathogenesis and immunology research. Such animals are not only
important for in vivo research, but also for in vitro studies
performed with primary cells obtained from these mice.
Importantly, BMDM obtained from transgenic mice are broadly
used as primary cells. Here, we describe a highly efficient method
for cryopreservation of murine BM cells for further differentiation
into BMDM. We demonstrate that cryopreserved BM can
maintain differentiation capacity for at least 6 years. Therefore,
this method represents a powerful tool for murine macrophage
research, as BMDM can be readily and easily generated from a
stock of frozen BM cells.
Preliminary investigation preformed herein indicates that bone
marrow-derived dendritic cells can be obtained from cryopre-
served BM cells (Fig. 6). Importantly DCs obtained from fresh and
cryopreserved BM cells equally respond to LPS as measured by
the expression of CD40, CD86 and MHC-II. These preliminary
results may indicate that the method described herein may also be
useful for dendritic cell research. However, further and extensive
characterization of the biology of dendritic cells obtained from
fresh or frozen BM cells will be required to allow routine use of
dendritic cells from cryopreserved BM cells. As for BMDM, we
demonstrate that macrophages obtained from fresh or frozen BM
cells do not differ for important macrophage functions such as
expression of CD86 and MHC-II in response to LPS or L.
pneumophila infection and restriction/support of intracellular
multiplication of the pathogenic bacteria L. pneumophila.
Importantly, the optimizations of the protocol performed herein
allow us to use 4610
6 BM cells per cryovial, which give rise to
about 10 million BMDM per cryovial. Therefore, the sacrifice of a
single mouse can generate several BM-containing cryovials
(usually from 4 to 10). This valuable material can be maintained
frozen for years and further used to perform independent
experiments. Finally, the development of the protocol described
herein not only saves researchers’ time and funds, but also reduces
the number of mice sacrificed, which are precious resources often
of limited supply.
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